Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BLRX
BLRX logo

BLRX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy BioLine RX Ltd (BLRX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
2.850
1 Day change
-9.72%
52 Week Range
5.060
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BLRX is not a good buy right now for a beginner-focused, long-term investor with $50,000-$100,000 to deploy. The stock lacks supportive catalyst news, has no bullish proprietary signal, shows only neutral-to-mixed technicals, and the short-term price pattern leans negative. My direct view: do not buy now.

Technical Analysis

Current trend is weakly mixed but not bullish. MACD histogram is negative and contracting, which points to fading momentum. RSI_6 at 59.75 is neutral-to-slightly positive, but not strong enough to confirm an entry. Moving averages are converging, suggesting indecision rather than a strong uptrend. Price is sitting near the pivot at 3.22 with resistance at 3.414 and 3.535, while support is at 3.025 and 2.905. The stock trend model suggests a 60% chance of decline over the next day, week, and month, which is unfavorable for an impatient buyer.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is not informative here because volume is zero and put open interest is zero. Call open interest exists at 462, but with no trading volume, the market is not showing active directional conviction. IV is extremely elevated at 878.61 with IV rank 86.51, which implies expensive implied pricing rather than a clean bullish setup. Overall, options data does not support an immediate long entry.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
2

Positive Catalysts

  • No recent news catalysts were reported. No AI Stock Picker signal. No SwingMax signal. Hedge funds and insiders are neutral, so there is no strong accumulation signal. The stock did show a regular market move of 3.63%, but this is not backed by a confirmed catalyst.

Neutral/Negative Catalysts

  • No news in the recent week means there is no fresh event-driven catalyst to drive a sustained move. Technical momentum is weak, the probability model favors downside, and proprietary signals are absent. The pre-market move was -1.89%, suggesting unstable sentiment. No congress trading data and no notable insider or hedge fund buying adds to the lack of conviction.

Financial Performance

Financial snapshot data was unavailable due to an error, so latest-quarter financial growth cannot be confirmed. Because the latest quarter season is not provided, there is no reliable evidence here to support a long-term growth thesis from the financials.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no evidence of improving Wall Street sentiment. Based on the available data, the Wall Street pros view appears cautious at best: no bullish upgrades, no price target momentum, and no supporting institutional or insider buying. The cons side dominates due to weak momentum, lack of catalysts, and absent conviction signals.

Wall Street analysts forecast BLRX stock price to rise
1 Analyst Rating
Wall Street analysts forecast BLRX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.157
sliders
Low
12
Averages
12
High
12
Current: 3.157
sliders
Low
12
Averages
12
High
12
No data

No data

People Also Watch